The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.

POMs are a class of inorganic metal-oxygen cluster compounds with broad-spectrum antitumor potential. However, their strong hydrophilicity and poor ...

New active ingredients such as antibodies are usually tested individually in laboratory animals. Researchers have now developed a technology that can be used to test around 25 antibodies ...

Jindal served as governor of Louisiana and as a U.S. assistant secretary of Health and Human Services. Katebi is deputy director of the Center for a Healthy America at the America First Policy ...

Biocon has launched Liraglutide, a drug for diabetes and obesity management, in the UK under the brand names Liraglutide Biocon and Biolide. This follows approval from the UK's MHRA, making Biocon the ...

The Hanson Wade Neuroimmunology Drug Development Summit is taking place February 25-27, 2025 in Boston, MA. The workshop, titled “Patient Stratification for Precision Medicine in Neuroscience ...

25 (UPI) --A new, wide-ranging review of existing scientific data released Tuesday is pointing to the possibility that dozens of commonly prescribed drugs could adversely affect brain development ...

National Key Laboratory of Macromolecular Drug Development and Manufacturing, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou 325035, China Oujiang Laboratory (Zhejiang Lab for ...

Experimental Drug Development Centre (EDDC), Agency for Science, Technology and Research (A*STAR), 10 Biopolis Road, #05-01, Chromos, 138670 Singapore *WX ([email protected]). Experimental Drug ...

Generic drugs have saved billions of dollars and benefited countless lives by making existing medicines more affordable. But a new study finds these drug copies may not all be created equal. Despite ...